Deferred versus immediate surgery for uterine fibroids: clinical trial results
- 1 May 1994
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 101 (s10) , 29-32
- https://doi.org/10.1111/j.1471-0528.1994.tb13683.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomasActa Obstetricia et Gynecologica Scandinavica, 1993
- The role of GnRH agonists in the treatment of uterine fibroidsBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniquesBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Goserelin (Zoladex®) in the treatment of fibroidsBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Risk of recurrence after myomectomyBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Use of Goserelin Depot, A Gonadotropin‐Releasing Hormone Agonist, for the Treatment of Menorrhagia and Severe Anemia in Women with Leiomyomata UteriActa Obstetricia et Gynecologica Scandinavica, 1990
- D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomasFertility and Sterility, 1989
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depotFertility and Sterility, 1987
- GOSERELIN THERAPY BEFORE SURGERY FOR UTERINE FIBROIDSThe Lancet, 1987